BMY vs NVS
Bristol Myers Squibb vs Novartis AG — AI-powered side-by-side comparison
| Metric | BMY | NVS |
|---|---|---|
| AI Score | 61 | 71 |
| Price | $63.63 | $154.44 |
| P/E Ratio | 14.02× | 23.58× |
| ROE | 38.2% | 30.5% |
| Revenue Growth YoY | — | — |
| Gross Margin | 70.2% | 74.3% |
| Debt / Equity | 1.93× | 1.18× |
| Dividend Yield | 3.9% | 2.9% |
| RSI (14) | 55.1 | 46.9 |
| Beta | 0.235 | 0.46 |
| Expected Upside | +4.1% | +1.2% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BMY Full Analysis
NVS Full Analysis